Consultation on draft guidance on Ministerial Reliance Order for certain human and veterinary drugs
Current status: Open
Opened on July 15, 2026, and will close to new input on September 12, 2026
Health Canada is seeking feedback on draft guidance on the Ministerial Reliance Order concerning decisions or documents on certain drugs by foreign regulatory authorities. This draft guidance sets out the regulatory requirements and process for manufacturers seeking deeming under the Order when filing human or veterinary drug submissions.
The guidance is to be read along with the Order.
Learn more:
- Order Providing for Reliance on Decisions of, or Documents Produced by, Foreign Regulatory Authorities in Respect of Certain Drugs
- Draft guidance on Ministerial Reliance Order concerning decisions or documents on certain drugs by foreign regulatory authorities
Also read the notice for the new draft guidance.
Join in: How to participate
Send us an email
Send an email to policy_bureau_enquiries@hc-sc.gc.ca with your ideas or comments. In the subject line of the email, use "Comments on Draft guidance on Ministerial reliance order for human and veterinary drugs".
Who is the focus of this consultation
We will engage with:
- industry (human and veterinary)
- health care professionals
Key questions for discussion
We are seeking your input on the following:
- Do you believe that specific sections or statements would benefit from more clarity (if so, please identify)?
- Do you have any other general suggestions or questions for us to consider?
Contact us
Bureau of Policy, Science and International Programs
Pharmaceutical Drugs Directorate
Health Products and Food Branch
Health Canada
Email: policy_bureau_enquiries@hc-sc.gc.ca